Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice.

Objective: To assess socio-sanitary expenditure after the addition of omalizumab to standard treatment in the control of severe asthma and to analyse its effectiveness under standard clinical practice.

Method: Observational retrospective multicentre study conducted in 12  pneumology services in the Valencian Community, Spain. Data from 186  patients were analysed.